Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Neurogene Inc. (NLTX)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Drug Manufacturers—Specialty & Generic
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
15 Aug 2023
BAKER BROS. ADVISORS LP
Director, 10% Owner
Neoleukin Therapeutics, Inc.
(NLTX)
489,092
+127%
2,285,342
$0.64
$1,463,486.60
SELL
10 Aug 2023
Smith Sean Michael
Interim CFO, Prin Acct Off, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
21,637
-5%
1,323
$0.62
$818.14
SELL
31 Mar 2023
Patel Priti
Former Chief Medical Officer
Neoleukin Therapeutics, Inc.
(NLTX)
37,313
-9%
3,769
$0.69
$2,607.77
SELL
1 Feb 2023
Smith Sean Michael
Principal Accounting Officer, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
15,960
-17%
3,316
$0.60
$1,980.32
SELL
1 Feb 2023
Patel Priti
Chief Medical Officer, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
31,082
-31%
14,380
$0.60
$8,587.74
SELL
10 Aug 2022
Smith Sean Michael
Principal Accounting Officer, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
6,776
-19%
1,655
$0.99
$1,640.77
SELL
30 Apr 2022
Patel Priti
Chief Medical Officer, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
6,462
-46%
5,538
$1.22
$6,748.61
BUY
24 Aug 2021
DRACHMAN JONATHAN G
President and CEO, Director, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
25,000
+120%
150,000
$6.22
$933,550.00
SELL
16 Jun 2021
Walkey Carl
Senior Vice President, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
1,352,489
-0%
600
$10.19
$6,114.00
SELL
9 Jun 2021
Walkey Carl
Senior Vice President, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
1,353,089
-0%
650
$10.82
$7,035.99
SELL
8 Jun 2021
Walkey Carl
Senior Vice President, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
1,353,739
-0%
600
$11.00
$6,600.00
SELL
4 Jun 2021
Walkey Carl
Senior Vice President, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
1,354,339
-0%
600
$10.00
$6,000.00
BUY
3 Jun 2021
DRACHMAN JONATHAN G
President and CEO, Director, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
2,248,686
+2%
50,000
$9.51
$475,354.00
SELL
26 May 2021
Walkey Carl
Senior Vice President, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
1,354,939
-0%
600
$10.00
$6,000.00
SELL
19 May 2021
Walkey Carl
Senior Vice President, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
1,355,539
-0%
600
$10.63
$6,378.00
SELL
12 May 2021
Walkey Carl
Senior Vice President, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
1,354,762
-0%
1,200
$11.09
$13,308.00
SELL
5 May 2021
Walkey Carl
Senior Vice President, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
1,355,962
-0%
1,200
$11.30
$13,560.00
SELL
28 Apr 2021
Walkey Carl
Senior Vice President, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
1,357,162
-0%
2,400
$12.58
$30,192.00
SELL
26 Apr 2021
Walkey Carl
Senior Vice President, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
1,359,562
-0%
600
$13.00
$7,800.00
SELL
21 Apr 2021
Walkey Carl
Senior Vice President, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
1,360,162
-0%
1,800
$11.98
$21,564.00
SELL
14 Apr 2021
Walkey Carl
Senior Vice President, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
1,361,962
-0%
1,800
$12.22
$21,996.00
SELL
7 Apr 2021
Walkey Carl
Senior Vice President, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
1,363,762
-0%
1,800
$12.02
$21,636.00
SELL
5 Apr 2021
Walkey Carl
Senior Vice President, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
1,365,562
-0%
600
$13.00
$7,800.00
SELL
31 Mar 2021
Walkey Carl
Senior Vice President, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
1,366,162
-0%
1,800
$11.96
$21,528.00
SELL
22 Mar 2021
Walkey Carl
Senior Vice President, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
1,367,962
-0%
2,400
$11.96
$28,715.94
SELL
17 Mar 2021
Walkey Carl
Senior Vice President, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
1,370,362
-0%
1,200
$11.36
$13,632.00
SELL
16 Mar 2021
Ho Robert
Chief Financial Officer, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
21,503
-23%
6,497
$11.01
$71,556.01
SELL
10 Mar 2021
Walkey Carl
Senior Vice President, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
1,371,562
-0%
1,800
$11.97
$21,540.06
SELL
3 Mar 2021
Walkey Carl
Senior Vice President, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
1,373,362
-0%
1,800
$11.87
$21,360.06
SELL
24 Feb 2021
Walkey Carl
Senior Vice President, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
1,375,162
-0%
2,400
$12.36
$29,652.00
SELL
17 Feb 2021
Walkey Carl
Senior Vice President, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
1,377,562
-0%
2,400
$12.70
$30,480.00
SELL
10 Feb 2021
Walkey Carl
Senior Vice President, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
1,379,962
-0%
3,000
$14.20
$42,600.00
SELL
5 Feb 2021
Walkey Carl
Senior Vice President, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
1,382,962
-0%
600
$14.00
$8,400.00
SELL
3 Feb 2021
Walkey Carl
Senior Vice President, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
1,383,562
-0%
2,400
$13.23
$31,752.00
BUY
7 Jul 2020
BAKER BROS. ADVISORS LP
Director
Neoleukin Therapeutics, Inc.
(NLTX)
320,049
+407%
424,000
$15.25
$6,466,000.00
BUY
27 Mar 2020
Redmile Group, LLC
10% Owner
Neoleukin Therapeutics, Inc.
(NLTX)
4,050,045
+4%
174,632
$10.43
$1,791,126.50
BUY
20 Dec 2019
BAKER BROS. ADVISORS LP
Director
Neoleukin Therapeutics, Inc.
(NLTX)
1,450,557
+192%
3,017,542
$8.40
$25,347,350.00
BUY
12 Nov 2019
DRACHMAN JONATHAN G
President and CEO, Director, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
2,198,686
+5%
119,047
$8.40
$999,994.75
BUY
9 Sep 2019
DRACHMAN JONATHAN G
See Remarks, Director, Officer
Neoleukin Therapeutics, Inc.
(NLTX)
584,428
+74%
250,000
$3.13
$781,746.56
BUY
6 Aug 2019
BAKER BROS. ADVISORS LP
Director, 10% Owner
AQUINOX PHARMACEUTICALS, INC
(AQXP)
1,177,013
+46%
371,525
$3.00
$1,115,615.50
SELL
14 May 2018
LEVITT DANIEL J
Director
AQUINOX PHARMACEUTICALS, INC
(AQXP)
0
-100%
3,906
$12.67
$49,489.02
SELL
15 Mar 2018
MacKenzie Lloyd
Chief Operating Officer, Officer
AQUINOX PHARMACEUTICALS, INC
(AQXP)
0
-100%
1,302
$14.63
$19,048.78
SELL
1 Jun 2017
Main David
President and CEO, Director, Officer
AQUINOX PHARMACEUTICALS, INC
(AQXP)
71,530
-17%
15,625
$13.26
$207,243.73
BUY
9 Jan 2017
BAKER BROS. ADVISORS LP
10% Owner
AQUINOX PHARMACEUTICALS, INC
(AQXP)
1,132,228
+54%
398,062
$17.18
$6,836,812.00
BUY
20 Sep 2016
BAKER BROS. ADVISORS LP
10% Owner
AQUINOX PHARMACEUTICALS, INC
(AQXP)
1,119,075
+167%
2,783,605
$12.25
$34,110,452.00
BUY
15 Mar 2016
BAKER BROS. ADVISORS LP
10% Owner
AQUINOX PHARMACEUTICALS, INC
(AQXP)
790,130
+148%
471,667
$7.99
$3,770,636.50
BUY
22 Jan 2016
BAKER BROS. ADVISORS LP
10% Owner
AQUINOX PHARMACEUTICALS, INC
(AQXP)
777,652
+22%
140,786
$10.80
$1,520,909.00
BUY
19 Jan 2016
BAKER BROS. ADVISORS LP
10% Owner
AQUINOX PHARMACEUTICALS, INC
(AQXP)
759,325
+33%
190,079
$9.33
$1,773,653.40
BUY
14 Jan 2016
BAKER BROS. ADVISORS LP
10% Owner
AQUINOX PHARMACEUTICALS, INC
(AQXP)
739,223
+37%
202,623
$8.28
$1,677,083.20
Home